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Abstract
Chagas disease (Ch) affects 8–10 million people in Latin America. Sudden death is the
major cause of death in patients with Ch. Objective: To compare the circadian rhythm of
sudden death in Ch vs. non-Ch patients. Methods: Retrospective analysis of all the cases
of sudden death (SD) is recorded in our department, including autopsied patients from
1963 until 2011. Pattern of death of 266 patients (116 Ch and 146 non-Ch), 56.7% men,
average age 54, 6 years old, divided into four groups: Group A: Ch with SD (n = 38),
Group B: non-Ch with SD (n = 58), Group C: Ch with non-SD (n = 81), and Group D: non-
Ch with non-SD (n = 89). Results: 44.7% (17/38) of sudden deaths in Group A (Ch)
occurred between 6 am and 5:59 pm, while for Group B (not Ch) 70.7% (41/58) died in
that time (p < 0.005). Between 6 pm and 5:59 am occurred 55.3% (21/38) of the SD in Group
A (Ch) compared with 29.3% (17/58) in Group B (p < 0.005). Conclusions: Circadian
rhythm of SD in patient with Ch differs from those patients with non-CH. In CH patients,
SD occurs predominantly during the night compared with non-Ch SD that occurs pre-
dominantly during the morning.
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1. Introduction
The Chagas disease is a malady caused by the Trypanosoma cruzi protozoan, and it represents an
endemic disease in Latin America, affecting 8–10 million of patients, most of them being poor
[1–2]. It is estimated that 400,000 infected persons live in nonendemic countries, mainly in the
United States and Europe [3, 4]. A recent meta-analysis of European studies that, in aggregate,
screened 10,000 Latin American immigrants found a positive serological test prevalence of 4.2%
[5]. Based on published seroprevalence in Latin American immigrant populations (1.31%), it was
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estimated that approximately 300,000 individuals with T. cruzi infection live in the United States,
with 30,000–45,000 cardiomyopathy cases and 63–315 congenital infections annually [6].
The sudden death circadian variation has been demonstrated in two large-scale studies, the
Framingham Heart Study [7] and the Massachusetts Death Certificate Study [8]. Both
studies show a peak of sudden deaths between 7 and 11 am with a lower incidence during
sleep, which is similar to the rate of ischemic and arrhythmic events [9, 10]. The sudden
death is the main cause of death in those patients with the Chagas disease, being responsi-
ble of the 55–65% of their deaths [11]. Lopes et al. [12] demonstrated that there is a sudden
death circadian rhythm in Chagasic patients. In this study, 50 cases of Chagasic sudden
death, along with 473 cases of nonsudden natural death, were compared in several centers.
To the best of our knowledge, this is the first report that compares the rhythm of the
sudden and nonsudden death of Chagasic patients vs. non-Chagasic patients with cases
within a same center.
2. Material and methods
A retrospective study of a consecutive series of sudden death cases, registered within our
department between 1963 and 2011, including the ECG records, Holter records from sudden
death victims, autopsies, and the Death report by the relatives. The Chagas disease diagnosis
was performed through serological studies, or a necroscopic study was performed in the cases
of autopsies.
The date and time of death were collected from necropsy protocols and/or emergency clinical
histories, as well as data obtained from relatives and witnesses.
Sudden cardiac death (SCD) is generally defined as a sudden and unexpected pulseless event,
but noncardiac conditions need to be excluded before the occurrence of a primary cardiac
event can be confirmed [13]. A case of established SCD is an unexpected death without
obvious extracardiac cause, occurring with a rapid witnessed collapse, or if unwitnessed,
occurring within 1 h after the onset of symptoms [13]. A probable SCD is an unexpected death
without obvious extracardiac cause that occurred within the previous 24 h [13]. In any situa-
tion, the death should not occur in the setting of a prior terminal condition, such as a malig-
nancy that is not in remission or end-stage chronic obstructive lung disease [13]. In our study,
we included both established and probable SCD.
A total of 266 cases were analyzed; 56.7% of the subjects were male with an average age of
54.6 years, which were divided into four groups: Group A: Chagasic patients with sudden
death, n = 38; Group B: non-Chagasic patients with sudden death, n = 58; Group C: Chagasic
patients with non-sudden death, n = 89; and Group D: non-Chagasic patients with non-sudden
death, n = 81.
The results were assessed using exploratory data analysis (EDA) and comparison of ratio
differential. As the statistic validation rule, a p-value <0.05 was considered as statistically
significant.
Circadian Rhythm - Cellular and Molecular Mechanisms146
3. Results
A total number of cases per hour of sudden death in patients with and without Ch are shown
in Figure 1. Figure 2 shows the number of cases per hour of nonsudden death in patients with
and without Ch. After analyzing the data divided into 12-h periods (day and night), significant
differences were observed. Figure 3 shows the percentages of cases from the SD groups
occurring during night and day. Forty four point seven per cent (44.7%) (17/38) of the sudden
deaths in Group A (Ch) occurred between 6 am and 5:59 pm, while for Group B (non-Ch),
70.7% (41/58) of the patients died within that time (p < 0.005). Between 6 pm and 5:59 am,
55.3% (21/38) of the deaths of Group A (Ch) occurred in that time compared to 29.3% (17/58)
from Group B (p < 0.005). Figure 4 shows the data of nonsudden death cases. 49.4% (40/81) of
Group C (Ch non-SD) died between 6 am and 5:59 pm compared to 59.6% (53/89) of Group D
(non-Ch, non-SD), (p not significant), while between 6 pm and 5:59 am, 50.6% of Group C (Ch,
non-SD) cases died compared to 40.4% (36/53) of Group D (non-Ch, non-SD) (p was not
significant).
In order to perform a more detailed analysis, the percentages of cases were grouped within 3-h
periods: (6–8, 9–11, 12–14, 15–17, 18–20, 21–23, 24–2, 3–5). Figure 5 shows the circadian
rhythm of sudden death in Chagasic patients (Group A) compared to the non-Chagasic
patients (Group B). Within these periods, a higher death percentage in the Chagasic group is
observed within the 21–23 h interval (34 vs. 3%, p = 0.0001), while the non-Chagasic arm
presented a higher percentage of cases within the 9–11 h range (43 vs. 3%, p < 0.0001), of 24 to
21 2 h (10 vs. 0% p < 0.005), and from 3 to 5 h (7 vs. 0%, p < 0.005). The difference of the other
analyzed periods was not significant. When comparing the number of cases of non-sudden
Figure 1. Sudden death of circadian rhythm.
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Figure 2. Circadian rhythm of nonsudden death.
Figure 3. Comparison of 12-h periods of sudden death of Chagasic and non-Chagasic patients.
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Figure 4. Comparison of 12-h periods of nonsudden death in Chagasic vs. non-Chagasic patients.
Figure 5. Sudden death circadian rhythm in Chagasic patients compared to non-Chagasic patients.
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deaths in Chagasic patients vs. non-Chagasic patients, a significant difference in any of the
analyzed ranges was not observed.
4. Discussion
The sudden death is the primary cause of death in patients suffering from Chagas disease,
representing around 60% of the total cases [11], hence the importance of its study. Our study
clearly evidenced that in Chagasic patients, the higher percentage of cases of sudden death
occurred during the nighttime (Figures 1, 3, and 5). When we analyzed the non-sudden death
results, no difference between the Chagasic and non-Chagasic arms was observed (Figures 2
and 4). Our results agree with those of Lopes et al. [8], who demonstrated a sudden death
predominance in Chagasic patients during the nighttime. On the other hand, our study also
agrees with previous studies in the non-Chagasic population in the United States, which were
a predominance of sudden death cases occurred in the morning [7, 8]. The importance of our
study lies in two milestones:
(1) This study represents the largest series reported to date comparing the sudden death
circadian rhythm in Chagasic and non-Chagasic patients. (2) The fact that this study represents
a series where all included patients belonged to the same center within a Latin American
country, allowing a better group comparison.
The potential mechanisms for the sudden death circadian variation in the general population
are not entirely clear, especially since due to the interaction among them, it is difficult to
independently determine the importance of each factor. The proposed mechanisms include:
a. Autonomic nervous system alterations.
It is being proposed that both the sympathetic nervous system and the parasympathetic
system may stimulate the circadian variation. Using the frequency domain, it has been
demonstrated an unfavorable variability profile of the heart rate in the morning time.
[14–17] This may be caused by both the sympathetic tone endogen variations and the
increasing level of physical activity [15–17]. The use of beta-blockers reduces or removes
the morning peak of ischemic and arrhythmic events [18–22], which supports the hypoth-
esis of increasing adrenergic tone, since this same effect is not achieved via antiarrhythmic
non-beta blockers medication [23]. Generally, the HRV indexes significantly decrease
during the daytime and increase during the night [24–30].On the other hand, the varia-
tions of autonomic tone and parasympathetic-sympathetic balance have been proposed as
the cause, which have been analyzed through heart rate variations (HRV) [31–35].
b. Morning variations of the electrophysical properties.
In both invasive electrophysiological studies [28] and non-invasive studies using perma-
nent pacemaker telemetry [15, 31], circadian variation of the ventricular refractory has
been demonstrated, being the last lower during the morning time and higher during sleep.
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This variation does not seem to be related to the potassium or circulating catecholamine
levels [31]; on the other hand, it would be aligned with the variations of the maximum QT
interval [33].
c. Circadian variation of ischemic episodes.
A peak in the morning and in the afternoon of ischemia-related conditions, such as the
myocardial infraction [22, 34, 35], anginal crisis [36–38], and strokes, [39, 40] has been
reported. These episodes have been related to morning variations of the endothelial function
[41] and of thrombogenesis biochemical markers [42–46]. Durgan et al. [47] demonstrated
that there is a relation between the date time and the tolerance to reperfusion-ischemia in
cardiomyocytes of isolated mice, being the lowest tolerance during the morning time.
The factors that may bias for the circadian rhythm to be different in patients with Chagas
disease are not clear; however, several hypotheses have been posed:
1. The autonomic balance of Chagasic patients, which has been evidenced by several authors
[48–50]. Cardiac autonomic dysfunction, characterized mainly by parasympathetic
depression, is present in human and experimental Chagas disease, even in patients with
minor ECG alterations [51].
2. The endothelial dysfunction [52].
3. The presence of antibodies against the adrenergic receivers may reduce the morning
adrenergic activity, hence, suppressing the morning peak [53].
Abello et al. [54], when analyzing 22 Chagasic patients with third-generation implantable
defibrillators, demonstrated a ventricular tachycardia circadian rhythm pattern, characterized
by a frequency peak between noon and 18:00 h with a nadir between 24:00 and 6:00 h, which
would be in line with our results.
5. Conclusion
The sudden death circadian rhythm in Chagasic patients significantly differs from that of the
non-Chagasic patients, showing a greater prevalence during the nighttime. Further studies are
needed in order to analyze both the prognostic implications and the therapeutic ones.
6. Limitations
Regarding the certainty of the time of death, the study limitation is common to that of all sudden
death studies, since the time of death, which is mostly reported by a witness, decreasing the
accuracy of the data. In most of the times, we ignored the personal history of the patients
(previous pathology, concomitant treatment, etc.) because the death occurred suddenly. Also,
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we do not have previous data from other complementary explorations such as echocardiogram,
stress test, and so on in much of the cases.
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